Treatment of ARDS

Chest

Volumn 120, Issue 4, 2001, Pages 1347-1367

  Brower, Roy G ^a   Ware, Lorraine B ^c   Berthiaume, Yves ^b   Matthay, Michael A ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Mechanical ventilation; Pulmonary edema; Ventilator associated lung injury

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CORTICOSTEROID; FLUOROCARBON; GLUCOCORTICOID; LISOFYLLINE; PENTOXIFYLLINE; PROSTAGLANDIN INHIBITOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; AERATION; AIRWAY PRESSURE; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BODY POSTURE; DISEASE ASSOCIATION; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; FLUID THERAPY; GAS EXCHANGE; HEMODYNAMICS; HIGH FREQUENCY VENTILATION; HOSPITAL INFECTION; HUMAN; INFLAMMATION; LUNG INJURY; NUTRITION; PATHOGENESIS; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; SURFACE TENSION; TIDAL VOLUME;

EID: 0034786199     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.4.1347     Document Type: Review

References (257)

1. Acute respiratory distress in adults
2. The acute respiratory distress syndrome
3. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
4. Interobserver variability in applying a radiographic definition for ARDS
5. Conference summary: Acute lung injury
6. Pulmonary edema and acute lung injury
7. Acute lung injury and the acute respiratory distress syndrome
8. Laparotomy for abdominal sepsis in the critically ill
9. Laparotomy for intra-abdominal sepsis in patients in an ICUs
10. Identification of patients with acute lung injury: Predictors of mortality
11. Causes of mortality in patients with the adult respiratory distress syndrom
12. Ventilation with end-expiratory pressure in acute lung disease
13. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome
14. Relationships between lung CT density, gas exchange, and Peep in acute respiratory failure
15. Preservation of normal lung regions in the adult respiratory distress syndrome: Analysis by computed tomography
16. Lung edema caused by high peak inspiratory pressures in dogs: Role of increased microvascular filtration pressure and permeability
17. Mechanisms of ventilator-induced lung injury
18. Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures
19. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: Protection by positive end-expiratory pressure
20. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation: An experimental study
21. Deleterious effects of mechanical ventilation on the lower lung
22. Mechanical ventilation-induced pulmonary edema: Interaction with previous lung alterations
23. Permissive hypercapnia
24. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome
25. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: A prospective study
26. Permissive hypercapnia: How permissive should we be?
27. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome: The Multi-center Trail Group on Tidal Volume Reduction in ARDS
28. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome: Pressure- and Volume-Limited Ventilation Strategy Group
29. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients
30. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
31. Time course of changes in lung permeability and edema in the rat exposed to 100% oxygen
32. Responses of baboons to prolonged hyperoxia: Physiology and qualitative pathology
33. 2
34. Pulmonary inflammation due to oxygen toxicity: Involvement of chemotactic factors and polymorphonuclear leukocytes
35. Oxygen toxicity
36. Pulmonary oxygen toxicity: A review
37. Oxygen toxicity in man: A prospective study in patients with irreversible brain damage
38. Potentiation of diffuse lung damage by oxygen: Determining variables
39. Superoxide dismutase and pulmonary oxygen toxicity
40. Oxygen toxicity: Augmentation of antioxidant defense mechanisms in rat lung
41. Simultaneous exposure of sheep to endotoxin and 100% oxygen
42. Endotoxin protection against oxygen-induced acute and chronic lung injury
43. Antioxidant activity of bronchoalveolar lavage fluid in the adult respiratory distress syndrome
44. Least PEEP: Primum non nocere
45. Hemody-namic management of the adult respiratory distress syndrome
46. Influence of positive end-expiratory pressure on left ventricular performance
47. The effects of positive end-expiratory pressure on right and left ventricular performance
48. Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS
49. Mechanism of decreased right and left ventricular end-diastolic volumes during continuous positive-pressure ventilation in dogs
50. Effects of positive end-expiratory pressure on the gradient for venous return
51. Adaptations of the peripheral circulation to PEEP
52. Alveolar pressure and lung volume as determinants of net transvascular fluid filtration
53. The effects of expiratory positive airway pressure on the resolution of oleic acid-induced lung injury in dogs
54. Extra-alveolar vessel fluid filtration coefficients in excised and in situ canine lobes
55. Effects of airway pressure on bronchial blood flow
56. Ventilator-induced lung injury: Lessons from experimental studies
57. Current concepts: Positive end-expiratory pressure in adult respiratory failure
58. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
59. Diagnosis and therapy of acute respiratory distress syndrome in adults: An international survey
60. How is mechanical ventilation employed in the intensive care unit?: An international utilization review
61. Cardiorespiratory effects of pressure-controlled ventilation with and without inverse ratio in the adult respiratory distress syndrome
62. Effects of pressure-controlled with different I:E ratios versus volume-controlled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome
63. Fluid and hemodynamic management in acute lung injury
64. The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome
65. Treatment of acute low pressure pulmonary edema in dogs: Relative effects of hydrostatic and oncotic pressure, nitroprusside, and positive end-expiratory pressure
66. Effect of furosemide in canine low-pressure pulmonary edema
67. Interactions between permeability and hydrostatic pressure in perfused dogs' lungs
68. Treatment of adult respiratory distress syndrome with diuretics, dialysis, and positive end-expiratory pressure
69. Fluid balance and the adult respiratory distress syndrome
70. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure
71. A prospective study of lung water measurements during patient management in an ICU
72. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization
73. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome
74. Multiple organ system failure and infection in adult respiratory distress syndrome
75. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
76. The adult respiratory distress syndrome: A report of survival and modifying factors
77. Evolving concepts in multiple organ failure syndrome
78. Temporal patterns of blood volume, hemodynamics, and oxygen transport in pathogenesis and therapy of postoperative adult respiratory distress syndrome
79. The oxygen delivery/consumption controversy: Approaches to management of the critically ill
80. Oxygen supply and utilization relationships: A reevaluation
81. Significance of pathologic oxygen supply dependency in critically ill patients: Comparison between measured and calculated methods
82. 2 on oxygen delivery in ARDS
83. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients
84. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients
85. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery
86. Prospective trial of supranormal values as goals of resuscitation in severe trauma
87. 2 as resuscitation endpoints in severe trauma
88. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study
89. Elevation of cardiac output and oxygen delivery improves outcome in septic shock
90. Elevation of systemic oxygen delivery in the treatment of critically ill patients
91. Tissue hypoxia: How to detect, how to correct, how to prevent; consensus conference
92. A multicenter randomized controlled clinical trial of transfusion requirements in critical care
93. Neuromuscular blockade in the ICUs: More than we bargained for
94. Treatment of canine low pressure pulmonary edema: Nitroprusside versus hydralazine
95. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction
96. Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome: A prospective trial
97. 1 Study Group
98. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions
99. Inhaled nitric oxide: Its effects on pulmonary circulation and airway smooth muscle cells
100. Inhaled nitric oxide in the adult respiratory distress syndrome and other lung diseases
101. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
102. Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep
103. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome
104. Inhaled nitric oxide for the adult respiratory distress syndrome
105. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial; Inhaled Nitric Oxide in ARDS Study Group
106. Result of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in ARDS
107. Pulmonary infection during the acute respiratory distress syndrome
108. Nosocomial pneumonia in patients with acute respiratory distress syndrome
109. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: Incidence and diagnosis
110. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia
111. Multiple organ system failure and infection in adult respiratory distress syndrome
112. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome
113. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects
114. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia
115. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies; a consensus statement
116. Applied nutrition in ICU patients: A consensus statement of the American College of Chest Physicians
117. Nutrition in the ICU: Are all systematics go?
118. TPN promotes bacterial translocation from the gut
119. TPN and bowel rest modify the metabolic response to endotoxins in humans
120. Enteral nutrition in the critically ill patient: A critical review of the evidence
121. Enteral nutrition-related gastrointestinal complications in critically ill patients: A multicenter study; the Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units
122. Total parenteral nutrition in the critically ill patient: A meta-analysis
123. Enteral nutrition does not prevent multiple organ failure syndrome (MOFS) after sepsis
124. 2 and reduces the period of ventilation in artificially ventilated patients
125. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: A meta-analysis of randomized controlled clinical trials
126. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group
127. Adult respiratory distress syndrome: Risk with common predispositions
128. Adverse effects of large tidal volume and low PEEP in canine acid aspiration
129. Tidal ventilation at low airway pressures can augment lung injury
130. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations
131. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: Different syndromes?
132. Injurious ventila-tory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model
133. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial
134. Noninvasive ventilation: Does it work, for whom, and how?
135. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
136. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
137. Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation
138. Noninvasive ventilation in acute respiratory failure
139. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
140. High frequency ventilation
141. Mechanisms of gas transport during ventilation by high-frequency oscillation
142. High frequency ventilation for acute lung injury and acute respiratory distress syndrome
143. High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants: The HIFI Study Group
144. High-frequency oscillatory ventilation for adult respiratory distress syndrome: Let’s get it right this time
145. The Provo multicenter early high-frequency oscillatory ventilation trial: Improved pulmonary and clinical outcome in respiratory distress syndrome
146. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure
147. Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome: HiFO Study Group
148. High-frequency jet ventilation: A prospective randomized evaluation
149. High-frequency oscillatory ventilation for adult respiratory distress syndrome: A pilot study
150. Use of ultrahigh frequency ventilation in patients with ARDS: A preliminary report
151. Modes of tracheal gas insufflation: Comparison of continuous and phase-specific gas injection in normal dogs
152. Tracheal gas insufflation during pressure-control ventilation: Effect of using a pressure relief valve
153. Expiratory phase tracheal gas insufflation and pressure control in sheep with permissive hypercapnia
154. Tracheal gas insufflation improves ventilatory efficiency during metha-choline-induced bronchospasm
155. Tracheal gas insufflation during pressure-control ventilation: Effect of catheter position, diameter, and flow rate
156. Proportional assist ventilation, a new approach to ventilatory support: Theory
157. Proportional assist ventilation: Results of an initial clinical trial
158. Inverse ratio ventilation in ARDS: Rationale and implementation
159. Pressure controlled inverse ratio ventilation in severe adult respiratory failure
160. Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation
161. Cardiorespiratory effects of pressure controlled inverse ratio ventilation in severe respiratory failure
162. Inverse ratio ventilation: PEEP in disguise
163. Pressure-controlled inverse-ratio ventilation: Panacea or auto-PEEP
164. Inverse ratio ventilation compared with PEEP in adult respiratory failure
165. Should inverse ratio ventilation be used in adult respiratory distress syndrome?
166. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation
167. Airway pressure release ventilation: A new concept in ventilatory support
168. Airway pressure release ventilation during acute lung injury: A prospective multicenter trial
169. Airway pressure release ventilation
170. Continuous positive airway pressure (CPAP) vs. intermittent mandatory pressure release ventilation (IMPRV) in patients with acute respiratory failure
171. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome
172. Surfactant and the adult respiratory distress syndrome
173. Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs
174. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome
175. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
176. Pathogenesis and treatment of the adult respiratory distress syndrome
177. Role of extracor-poreal circulation in adult respiratory distress syndrome management
178. Extracorporeal membrane oxygenation in severe acute respiratory failure: A randomized prospective study
179. Extracorporeal membrane oxygenation: A breath of fresh air or yesterday’s treatment
180. 2 removal in severe acute respiratory failure
181. Extracorporeal carbon dioxide removal technique improves oxygenation without causing overinflation
182. Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation: Improvement in arterial oxygenation with reduction of risk of pulmonary barotrauma in patients with adult respiratory distress syndrome
183. 2 removal for adult respiratory distress syndrome
184. Prone positioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS
185. The effects of long-term prone positioning in patients with trauma-induced adult respiratory distress syndrome
186. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury
187. Effect of the prone position on patients with hydrostatic pulmonary edema compared with patients with acute respiratory distress syndrome and pulmonary fibrosis
188. Mechanism by which the prone position improves oxygenation in acute lung injury
189. Ventilation in the prone position: The Prone-Supine Study Collaborative Group
190. Prone ventilation
191. Perfluorochemical liquid ventilation: From the animal laboratory to the ICUs
192. Liquid ventilation
193. Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome
194. Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: Dose-dependent improvement of gas exchange
195. Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome
196. Efficacy of perfluorocarbon partial liquid ventilation in a large animal model of acute respiratory failure
197. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome
198. Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome
199. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome: The LiquiVent Study Group
200. Biological markers of acute lung injury: Prognostic and pathogenetic significance (state of the art)
201. The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study
202. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
203. High-dose corti-costeroids in patients with the adult respiratory distress syndrome
204. Efficacy and safety of recombinant human activated protein C for severe sepsis
205. Severe sepsis: A new treatment with both anticoagulant and anti-inflammatory properties
206. Fibroprolifera-tive phase of ARDS: Clinical findings and effects of cortico-steroids
207. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: Patterns of response and outcome
208. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
209. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function
210. Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome
211. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity, and mortality
212. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study
213. Influence of N-acetyl-cysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study
214. 1 (TLC C-53) in acute respiratory distress syndrome: Acontrolled, randomized, double-blind, multicenter clinical trial; TLC C-53 ARDS Study Group
215. Ketoconozole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome)
216. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome
217. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: A randomized controlled trial
218. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog
219. Effect of pentoxi-fylline on hemodynamics, alveolar fluid reabsorption, and pulmonary edema in a model of acute lung injury
220. The effect of pentoxifylline on acid-induced alveolar epithelial injury
221. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome
222. Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids
223. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo
224. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid
225. A randomized placebo controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome
226. Acid aspiration induced lung injury in rabbits is mediated by interleu-kin-8 dependent mechanisms
227. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality
228. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
229. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury
230. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
231. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis
232. Alveolar epithelial damage: A critical difference between high pressure and oleic acid induced low pressure pulmonary edema
233. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans
234. Salt and water transport across alveolar and distal airway epithelium in the adult lung
235. β-Adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs
236. Alveolar fluid clearance persists in the presence of moderate left atrial hypertension in sheep
237. Alveolar epithelial fluid clearance mechanisms are intact after moderate hyper-oxic lung injury in rats
238. Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury
239. Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia
240. Inhibition of β-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock
241. 2 receptor stimulation
242. Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium
243. Alveolar type II cell growth on a pulmonary endothelial extracellular matrix
244. Failure of lung repair following acute lung injury: Regulation of the fibro-proliferative response; part 1
245. Acute lung injury: Pathogenesis of intraalveolar fibrosis
246. Transforming growth factor-α (TGF-α) enhances alveolar epithelial type II cell repair in a new in vitro model
247. Early detection of type III procollagen peptide in acute lung injury: Pathogenic and prognostic significance
248. Upregulation of alveolar epithelial fluid transport after subacute lung injury in rats from bleomycin
249. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats
250. Keratinocyte growth factor reduces lung damage due to acid instillation in rats
251. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality
252. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993
253. Reduced mortality in association with the acute respiratory distress syndrome (ARDS)
254. Health-related quality of life after acute lung injury
255. Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients